Zimberelimab (GLS-010) is a humanized monoclonal antibody targeting PD-1, with antitumor activity. It blocks the interaction between PD-L1, PD-L2, and PD-1 on the cell surface, and is used in studies of cervical cancer and non-small cell lung cancer.
Purity:
95.00%
CAS Number:
[2259860-24-5]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted